I. Historique and :. .. ,

. E. Ii,

I. B. En-france and :. .. ,

I. E. Place,

I. E. Le and . Sds, severity dependance scale"

. , Quel(s) traitement(s) prophylactique médicamenteux

I. G. Facteurs-de-risque-de-rechute and .. .. ,

. , 2.b.Le suivi après sevrage par le médecin généraliste

. , 1.b.Un programme d'éducation thérapeutique peut être mis en place

I. Limites-de-la-revue and :. .. , Difficultés pour le médecin généraliste à la réalisation d'un diagnostic

A. Ferrari, A. Cicero, A. Bertolini, S. Leone, G. Pasciullo et al., Need for Analgesics/drugs of Abuse: A Comparison Between Headache Patients and Addicts by the Leeds Dependence Questionnaire (LDQ), Les seuils sont : ? <10 : faible dépendance ? 10-22 : dépendance intermédiaire ? >22 : dépendance importante source, vol.26, pp.187-93, 2006.

, Migraine chronique selon les critères IHS: (ICHD ?3)

A. , Céphalée présente au moins 15 jours par mois depuis au moins 3 mois B. Céphalée survenant chez un patient ayant présenté au préalable au moins 5 crises de migraines avec ou sans aura C. Céphalée présente au moins 8 jours par mois et répondant aux critères C et D de la migraine sans aura ou aux critères B et C de la migraine avec aura et/ou répondant à un traitement

, Céphalée de tension chronique selon les critères IHS: (ICHD ?3)

A. , Céphalée présente au moins 15 jours par mois depuis au moins 3 mois B. Céphalée durant des heures ou jours ou continue C. Au moins 2 caractéristiques suivantes: 1. localisation bilatérale 2

, non aggravée par les activités physiques de routine D. Présence des deux éléments suivant: 1.pas plus d'un élément : photophobie

, Hemicrania Continua selon les critères IHS: (ICHD ?3)

A. Céphalée and B. , Présente depuis au moins 3 mois avec des exacerbations avec intensité modérée à plus importante C

, Au moins un des symptomes ou signes suivant ipsilatéral à la céphalée: a. Larmoiement et/ou injection conjonctivale b. Congestion nasale et/ou rhinorrhée c. Oedème palpébral d. Sueur du front et du visage e. Rougeur du front et de la face f

, Céphalée chronique de novo selon les critères IHS: A. Céphalée persistante répondant aux critères B et C B. Début distinct et clairement mémorisé, avec une douleur devenant continue et sans rémission en 24h C.Présente depuis au moins 3 mois D. Céphalée non attribuable à une autre cause BIBLIOGRAPHIE : 1. Boes CJ, Capobianco DJ. Chronic migraine and medication-overuse headache through the ages, Cephalalgia, vol.25, issue.5, pp.378-390, 2005.

W. Q. Wolfson, M. D. , J. R. Graham, and M. D. , Development of Tolerance to Ergot Alkaloids in a Patient with Unusually Severe Migraine, N Engl J Med, vol.241, pp.296-298, 1949.

G. A. Peters and B. T. Horton, Headache: with special reference to the excessive use of ergotamine preparations and withdrawal effects, Mayo Clin Proc, vol.26, issue.9, pp.153-61, 1951.

B. T. Horton and G. A. Peters, Clinical manifestations of excessive use of ergotamine preparations and management of withdrawal effect: report of 52 cases, Headache: The Journal of Head and Face Pain, vol.2, issue.4, pp.214-229, 1963.

C. Baumgartner, P. Wessely, C. Bingöl, J. Maly, and F. Holzner, Longterm Prognosis of Analgesic Withdrawal in Patients with Drug-Induced Headaches, Headache: The Journal of Head and Face Pain, vol.29, issue.8, pp.510-514, 1989.

V. Limmroth, S. Kazarawa, G. Fritsche, and H. C. Diener, Headache after frequent use of new 5-HT agonists zolmitriptan and naratriptan, Lancet, vol.353, p.378, 1999.

V. Limmroth, Z. Katsarava, G. Fritsche, S. Przywara, and H. C. Diener, Features of medication overuse headache following overuse of different acute headache drugs, Neurology, vol.59, issue.7, pp.1011-1015, 2002.

, Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain, Cephalalgia, vol.8, issue.7, pp.1-96, 1988.

S. D. Silberstein, R. B. Lipton, and S. Solomon, Classification of daily and near-daily headaches: Proposed revisions to the IHS criteria, Headache, vol.34, pp.1-7, 1994.

, Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, Cephalalgia, vol.24, issue.1, pp.1-160, 2004.

S. D. Silberstein, J. Olesen, and M. G. Bousser, ICHD-II)-revision of criteria for 8.2 Medication overuse headache, Cephalalgia, vol.25, pp.460-465, 2005.

, Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, Cephalalgia, vol.33, pp.629-808, 2013.

M. L. Westergaard, E. H. Hansen, C. Glümer, J. Olesen, and R. H. Jensen, Definitions of medicationoveruse headache in population-based studies and their implications on prevalence estimates: A systematic review, Cephalalgia, vol.34, issue.6, pp.409-434, 2014.

J. Park, H. Moon, J. Kim, K. Lee, and M. K. Chu, Chronic Daily Headache in Korea: Prevalence, Clinical Characteristics, Medical Consultation and Management, Journal of Clinical Neurology, vol.10, issue.3, p.236, 2014.

I. Ayzenberg, Z. Katsarava, A. Sborowski, M. Chernysh, V. Osipova et al., The prevalence of primary headache disorders in Russia: A countrywide survey, Cephalalgia, vol.32, issue.5, pp.373-81, 2012.

S. J. Wang, J. L. Fuh, S. R. Lu, C. Y. Liu, L. C. Hsu et al., Chronic daily headache in Chinese elderly Prevalence, risk factors, and biannual follow-up, Neurology, vol.54, issue.2, pp.314-314, 2000.
DOI : 10.1212/wnl.54.2.314

S. J. Wang, J. L. Fuh, S. R. Lu, and K. D. Juang, Chronic daily headache in adolescents Prevalence, impact, and medication overuse, Neurology, vol.66, issue.2, pp.193-197, 2006.
DOI : 10.1212/01.wnl.0000183555.54305.fd

G. Dyb, T. L. Holmen, and J. A. Zwart, Analgesic overuse among adolescents with headache The Head-HUNT-Youth Study, Neurology, vol.66, issue.2, pp.198-201, 2006.
DOI : 10.1212/01.wnl.0000193630.03650.19

P. Zeeberg, J. Olesen, and R. Jensen, Probable medication-overuse headache: The effect of a 2-month drug-free period, Neurology, vol.66, pp.1894-1898, 2006.

C. A. Meskunas, S. J. Tepper, A. M. Rapoport, F. D. Sheftell, and M. E. Bigal, Medications Associated with Probable Medication Overuse Headache Reported in a Tertiary Care Headache Center Over a 15-Year Period. CME. Headache: The Journal of Head and Face Pain, vol.46, pp.766-72, 2006.

M. E. Bigal, A. M. Rapoport, F. D. Sheftell, S. J. Tepper, and R. B. Lipton, Transformed migraine and medication overuse in a tertiary headache centre-clinical characteristics and treatment outcomes, Cephalalgia, vol.24, issue.6, pp.483-490, 2004.
DOI : 10.1111/j.1468-2982.2004.00691.x

M. Chiappedi and U. Balottin, Medication Overuse Headache in Children and Adolescents, Current Pain and Headache Reports, vol.18, issue.4, 2014.

J. Cuvellier, H. Nasser, and L. Vallée, Medication Overuse Headache in School-Aged Children: More Common Than Expected, Headache: The Journal of Head and Face Pain, vol.53, pp.387-388, 2013.

M. L. Westergaard, C. Glümer, E. H. Hansen, and R. H. Jensen, Prevalence of chronic headache with and without medication overuse: Associations with socioeconomic position and physical and mental health status: Pain, vol.155, pp.2005-2018, 2014.

M. Lantéri-minet, Headache associated with mis-use of analgesics, Rev Neurol, vol.161, pp.6-7, 2005.

M. Linde, A. Gustavsson, L. J. Stovner, T. J. Steiner, ?. Barr et al., The cost of headache disorders in Europe: the Eurolight project: Cost of headache in Europe, European Journal of Neurology, vol.19, issue.5, pp.703-714, 2012.

M. Lantéri-minet, G. Duru, M. Mudge, and S. Cottrell, Quality of life impairment, disability and economic burden associated with chronic daily headache, focusing on chronic migraine with or without medication overuse: A systematic review, Cephalalgia, vol.31, issue.7, pp.837-50, 2011.

D. Braunstein, A. Donnet, V. Pradel, V. Sciortino, V. Allaria-lapierre et al., Triptans use and overuse: A pharmacoepidemiology study from the French health insurance system database covering 4.1 million people, Cephalalgia, vol.35, issue.13, pp.1172-80, 2015.

T. J. Steiner, L. J. Stovner, and T. Vos, GBD 2015: migraine is the third cause of disability in under 50s. The Journal of Headache and Pain, vol.17, 2016.

M. Lantéri-minet, G. Duru, M. Mudge, and S. Cottrell, Quality of life impairment, disability and economic burden associated with chronic daily headache, focusing on chronic migraine with or without medication overuse: A systematic review, Cephalalgia, vol.31, issue.7, pp.837-50, 2011.

E. Altintas, K. Goksel, B. Taskintuna, N. Sariturk, and C. , Correlation Between Life Events and Quality of Life in Patients with Medication-Overuse Headache. Noro Psikiyatri Arsivi, vol.52, pp.233-242, 2015.

D. , D. Usai, S. Grazzi, L. Rigamonti, A. Solari et al., Quality of life and disability in primary chronic daily headaches, Neurological Sciences, vol.24, pp.97-100, 2003.

N. J. Wiendels, A. Van-haestregt, A. K. Neven, P. Spinhoven, F. G. Zitman et al., Chronic frequent headache in the general population: comorbidity and quality of life, Cephalalgia, vol.26, issue.12, pp.1443-1450, 2006.

D. &apos;amico, D. Grazzi, L. Usai, S. Rigamonti, A. Curone et al., Disability Pattern in Chronic Migraine With Medication Overuse: A Comparison With Migraine Without Aura, The Journal of Head and Face Pain, vol.45, pp.553-560, 2005.

A. Raggi, A. M. Giovannetti, M. Leonardi, S. Schiavolin, D. &apos;amico et al., Disability and mood state in patients with episodic and chronic migraine associated to medication overuse, Neurological Sciences, vol.33, issue.S1, pp.169-71, 2012.

T. J. Steiner, L. J. Stovner, Z. Katsarava, J. M. Lainez, C. Lampl et al., The impact of headache in Europe: principal results of the Eurolight project. The journal of headache and pain, vol.15, p.31, 2014.

A. Raggi, S. Schiavolin, M. Leonardi, A. M. Giovannetti, G. Bussone et al., Chronic migraine with medication overuse: Association between disability and quality of life measures, and impact of disease on patients' lives, Journal of the Neurological Sciences, vol.348, issue.1-2, pp.60-66, 2015.

J. R. Saper and A. E. Lake, Medication overuse headache: type I and type II, Cephalalgia, vol.26, issue.10, pp.1262-1262, 2006.

R. B. Lipton and M. E. Bigal, Chronic daily headache Is analgesic overuse a cause or a consequence?, Neurology, vol.61, issue.2, pp.154-155, 2003.

M. E. Bigal and R. B. Lipton, Overuse of acute migraine medications and migraine chronification. Current pain and headache reports, vol.13, pp.301-307, 2009.

A. Bahra, M. Walsh, . Menon, and P. J. Goadsby, Does chronic headache arise de novo in association with regular use of analgesics?.Headache: The Journal of head and face pain, vol.43, pp.179-190, 2003.

S. M. Wilkinson, W. J. Becker, and J. A. Heine, Opiate use to control bowel motility may induce chronic daily headache in patients with migraine, Headache: The Journal of Head and Face Pain, vol.41, issue.3, pp.303-309, 2001.

L. Williams, K. O&apos;connell, and N. Tubridy, Headaches in a rheumatology clinic: when one pain leads to another, European Journal of Neurology, vol.15, issue.3, pp.274-281, 2008.

C. W. Schmid, K. Maurer, D. M. Schmid, E. Alon, D. R. Spahn et al., Prevalence of medication overuse headache in an interdisciplinary pain clinic. The journal of headache and pain, vol.14, p.4, 2013.

H. C. Diener and V. Limmroth, Medication-overuse headache: a worldwide problem, Lancet Neurol, vol.3, pp.475-83, 2004.

S. Evers and M. Marziniak, Clinical features, pathophysiology, and treatment of medication-overuse headache, The Lancet Neurology, vol.9, issue.4, pp.391-401, 2010.

C. Créac&apos;h, F. Radat, G. Mick, E. Guegan-massardier, G. P. Guy et al., One or Several Types of Triptan Overuse Headaches? Headache: The Journal of Head and Face Pain, 2009.

J. A. Zwart, G. Dyb, K. Hagen, S. Svebak, and J. Holmen, Analgesic use: a predictor of chronic pain and medication overuse headache. The Head-HUNT Study, Neurology, vol.61, issue.2, pp.160-164, 2003.

K. Hagen, M. Linde, T. J. Steiner, L. J. Stovner, and J. Zwart, Risk factors for medication-overuse headache: An 11-year follow-up study. The Nord-Tr?ndelag Health Studies: Pain, 2012.

K. Paemeleire, A. Bahra, S. Evers, M. S. Matharu, and P. J. Goadsby, Medication-overuse headache in patients with cluster headache, Neurology, vol.67, issue.1, pp.109-122, 2006.

R. M. Desouza, A. Toma, and L. Watkins, Medication overuse headache-An under-diagnosed problem in shunted idiopathic intracranial hypertension patients, Br J Neurosurg, pp.1-5, 2014.

L. Baandrup and R. Jensen, Chronic Post-Traumatic Headache-A Clinical Analysis in Relation to the International Headache Classification 2nd Edition, Cephalalgia, vol.25, issue.2, pp.132-140, 2005.

J. Fuh, S. Wang, S. Lu, and K. Juang, Does medication overuse headache represent a behavior of dependence?: Pain, vol.119, pp.49-55, 2005.

F. Radat, C. Creach, E. Guegan-massardier, M. G. Guy, N. Fabre et al., Behavioral Dependence in Patients With Medication Overuse Headache: A Cross-Sectional Study in Consulting Patients Using the DSM-IV Criteria. Headache: The Journal of Head and Face Pain, vol.48, pp.1026-1062, 2008.

R. B. Grande, K. Aaseth, J. ?. Benth, . Gulbrandsen, M. B. Russell et al., The Severity of Dependence Scale detects people with medication overuse: the Akershus study of chronic headache, Neurosurgery & Psychiatry, vol.80, issue.7, pp.784-789, 2009.

F. Radat, S. Irachabal, M. Lafittau, C. Creac&apos;h, V. Dousset et al., Construction of a Medication Dependence Questionnaire in Headache Patients (MDQ-H) Validation of the French Version. Headache: The Journal of Head and Face Pain, vol.46, pp.233-242, 2006.

E. Lauwerier, K. Paemeleire, S. Van-damme, L. Goubert, and G. Crombez, Medication use in patients with migraine and medication-overuse headache: the role of problem-solving and attitudes about pain medication, Pain, vol.152, issue.6, pp.1334-1339, 2011.

P. Jonsson, A. Jakobsson, G. Hensing, M. Linde, C. D. Moore et al., Holding on to the indispensable medication-a grounded theory on medication use from the perspective of persons with medication overuse headache. The journal of headache and pain, vol.14, p.43, 2013.

A. Ferrari, A. Cicero, A. Bertolini, S. Leone, G. Pasciullo et al., Need for Analgesics/drugs of Abuse: A Comparison Between Headache Patients and Addicts by the Leeds Dependence Questionnaire (LDQ), Cephalalgia, vol.26, issue.2, pp.187-93, 2006.

F. Galli, G. Pozzi, A. Frustaci, A. M. Anastasi, S. Chirumbolo et al., Differences in the Personality Profile of Medication-Overuse Headache Sufferers and Drug Addict Patients: A Comparative Study Using MMPI-2, Headache: The Journal of Head and Face Pain, vol.51, issue.8, pp.1212-1239, 2011.

B. Biagianti, L. Grazzi, O. Gambini, S. Usai, R. Muffatti et al., Decision-making deficit in chronic migraine patients with medication overuse, Neurological Sciences, vol.33, issue.S1, pp.151-156, 2012.

M. E. Bigal, D. Serrano, D. Buse, A. Scher, W. F. Stewart et al., Acute Migraine Medications and Evolution From Episodic to Chronic Migraine: A Longitudinal PopulationBased Study. Headache: The Journal of Head and Face Pain, vol.48, pp.1157-68, 2008.

K. Thorlund, C. Sun-edelstein, E. Druyts, S. Kanters, S. Ebrahim et al., Risk of medication overuse headache across classes of treatments for acute migraine. The Journal of Headache and Pain, vol.17, 2016.

A. Roussin, A. Bouyssi, L. Pouché, L. Pourcel, and M. Lapeyre-mestre, Misuse and Dependence on Non-Prescription Codeine Analgesics or Sedative H1 Antihistamines by Adults: A CrossSectional Investigation in France, PLoS ONE, vol.8, issue.10, p.76499, 2013.

M. L. Westergaard, E. H. Hansen, C. Glümer, and R. H. Jensen, Prescription pain medications and chronic headache in Denmark: implications for preventing medication overuse, European Journal of Clinical Pharmacology, vol.71, issue.7, pp.851-60, 2015.

E. Mehuys, K. Paemeleire, T. Van-hees, T. Christiaens, V. Bortel et al., Self-medication of regular headache: a community pharmacy-based survey: Self-medication of regular headache, European Journal of Neurology, vol.19, issue.8, pp.1093-1102, 2012.

P. Jonsson, M. Linde, G. Hensing, and T. Hedenrud, Sociodemographic differences in medication use, health-care contacts and sickness absence among individuals with medication-overuse headache. The Journal of Headache and Pain, vol.13, pp.281-90, 2012.

E. S. Kristoffersen, R. B. Grande, K. Aaseth, C. Lundqvist, and M. B. Russell, Management of primary chronic headache in the general population: the Akershus study of chronic headache. The Journal of Headache and Pain, vol.13, pp.113-133, 2012.

C. Lucas, G. Geraud, D. Valade, M. Chautard, and M. Lanteri-minet, Recognition and Therapeutic Management of Migraine in 2004, in France: Results of FRAMIG 3, a French Nationwide Population-Based Survey. Headache: The Journal of Head and Face Pain, vol.46, pp.715-740, 2006.

H. T. Atasoy, A. E. Unal, N. Atasoy, U. Emre, and M. Sumer, Low Income and Education Levels May Cause Medication Overuse and Chronicity in Migraine Patients, Headache: The Journal of Head and Face Pain, vol.45, pp.25-31, 2005.

H. T. Atasoy, N. Atasoy, A. E. Unal, U. Emre, and M. Sumer, Psychiatric comorbidity in medication overuse headache patients with pre-existing headache type of episodic tension-type headache, European Journal of Pain, vol.9, issue.3, pp.285-285, 2005.

P. Sarchielli, I. Corbelli, P. Messina, L. M. Cupini, G. Bernardi et al., Psychopathological comorbidities in medication-overuse headache: a multicentre clinical study, European Journal of Neurology, vol.23, issue.1, pp.85-91, 2016.

F. Radat, C. Creac&apos;h, J. D. Swendsen, M. Lafittau, S. Irachabal et al., Psychiatric comorbidity in the evolution from migraine to medication overuse headache, Cephalalgia, vol.25, issue.7, pp.519-522, 2005.

A. E. Lake, Medication Overuse Headache: Biobehavioral Issues and Solutions. Headache: The Journal of Head and Face Pain, vol.46, pp.88-97, 2006.

G. Sances, F. Galli, S. Anastasi, N. Ghiotto, D. Giorgio et al., MedicationOveruse Headache and Personality: A Controlled Study by Means of the MMPI-2. Headache: The Journal of Head and Face Pain, vol.50, pp.198-209, 2010.

M. E. Bigal, F. D. Sheftell, A. M. Rapoport, S. J. Tepper, R. Weeks et al., MMPI personality profiles in patients with primary chronic daily headache: a case-control study, Neurological Sciences, vol.24, issue.3, pp.103-113, 2003.

S. Cevoli, E. Sancisi, D. Grimaldi, G. Pierangeli, S. Zanigni et al., Family History for Chronic Headache and Drug Overuse as a Risk Factor for Headache Chronification. Headache: The Journal of Head and Face Pain, vol.49, pp.412-420, 2009.

M. L. Westergaard, C. Glümer, E. H. Hansen, and R. H. Jensen, Medication overuse, healthy lifestyle behaviour and stress in chronic headache: Results from a population-based representative survey, Cephalalgia, vol.36, issue.1, pp.15-28, 2016.

Z. He, L. Dong, Y. Zhang, Q. Kong, G. Tan et al., Metabolic syndrome in female migraine patients is associated with medication overuse headache: a clinic-based study in China, European Journal of Neurology, vol.22, issue.8, pp.1228-1262, 2015.

M. Lafittau, F. Radat, S. Irachabal, and C. Creac&apos;h, Migraine et migraine transformée avec abus médicamenteux: quelles différences en termes de handicap, de détresse émotionnelle et de stratégies de coping?, L'Encéphale, vol.32, issue.2, pp.231-237, 2006.

M. Gómez-beldarrain, A. , A. Aguirre-larracoechea, U. Oroz, I. García-moncó et al., Low cognitive reserve is associated with chronic migraine with medication overuse and poor quality of life, Cephalalgia, vol.35, issue.8, pp.683-91, 2015.

M. E. Bigal and R. B. Lipton, The differential diagnosis of chronic daily headaches: an algorithmbased approach. The Journal of Headache and Pain, vol.8, pp.263-72, 2007.

D. Kernick and S. Williams, Should GPs have direct access to neuroradiological investigation when adults present with headache?, Br J Gen Pract, vol.61, issue.587, pp.409-411, 2011.
DOI : 10.3399/bjgp11x578124

URL : http://europepmc.org/articles/pmc3103688?pdf=render

D. Phillip, A. C. Lyngberg, and R. Jensen, Assessment of headache diagnosis. A comparative population study of a clinical interview with a diagnostic headache diary, Cephalalgia, vol.27, issue.1, pp.1-8, 2007.

C. Tassorelli, G. Sances, A. M. Ghiotto, N. Bendtsen, L. Olesen et al., The usefulness and applicability of a basic headache diary before first consultation: results of a pilot study conducted in two centres, Cephalalgia, vol.28, issue.10, pp.1023-1030, 2008.

R. Jensen, C. Tassorelli, P. Rossi, A. M. Osipova, V. Steiner et al., A basic diagnostic headache diary (BDHD) is well accepted and useful in the diagnosis of headache. A multicentre European and Latin American study, Cephalalgia, vol.31, issue.15, pp.1549-60, 2011.

M. Allena, M. G. Cuzzoni, C. Tassorelli, G. Nappi, and F. Antonaci, An electronic diary on a palm device for headache monitoring: a preliminary experience. The Journal of Headache and Pain, vol.13, pp.537-578, 2012.
DOI : 10.1007/s10194-012-0473-2

URL : https://thejournalofheadacheandpain.biomedcentral.com/track/pdf/10.1007/s10194-012-0473-2

M. Maizels and R. Burchette, Rapid and sensitive paradigm for screening patients with headache in primary care settings, Headache: The Journal of Head and Face Pain, vol.43, issue.5, pp.441-450, 2003.
DOI : 10.1046/j.1526-4610.2003.03088.x

V. Dousset, M. Maud, M. Legoff, F. Radat, B. Brochet et al., Probable medications overuse headaches: validation of a brief easy-to-use screening tool in a headache centre. The journal of headache and pain, vol.14, p.81, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00870624

K. Hagen, J. Zwart, A. H. Aamodt, K. B. Nilsen, G. Bråthen et al., The validity of questionnaire-based diagnoses: the third Nord-Trøndelag Health Study, The Journal of Headache and Pain, vol.11, issue.1, pp.67-73, 2006.

C. Lundqvist, K. Aaseth, R. B. Grande, J. ?. Benth, and M. B. Russell, The severity of dependence score correlates with medication overuse in persons with secondary chronic headaches. The Akershus study of chronic headache: Pain, vol.148, pp.487-91, 2010.

P. Zeeberg, J. Olesen, and R. Jensen, Discontinuation of Medication Overuse in Headache Patients: Recovery of Therapeutic Responsiveness, Cephalalgia, vol.26, issue.10, pp.1192-1200, 2006.

C. Créac&apos;h, P. Frappe, and M. Cancade, In-patient versus out-patient withdrawal programmes for medication overuse headache: A 2-year randomized trial, Cephalalgia, vol.31, pp.1189-1198, 2011.

P. Rossi, C. D. Lorenzo, J. Faroni, F. Cesarino, and G. Nappi, Advice Alone Vs. Structured Detoxification Programmes for Medication Overuse Headache: A Prospective, Randomized, Open-Label Trial in Transformed Migraine Patients With Low Medical Needs, Cephalalgia, vol.26, issue.9, pp.1097-105, 2006.

R. B. Grande, K. Aaseth, J. Benth, C. Lundqvist, and M. B. Russell, Reduction in medicationoveruse headache after short information. The Akershus study of chronic headache: Reduction in medication-overuse headache after short information, European Journal of Neurology, vol.18, issue.1, pp.129-166, 2011.
DOI : 10.1111/j.1468-1331.2010.03094.x

P. Rossi, J. V. Faroni, and G. Nappi, Short-term effectiveness of simple advice as a withdrawal strategy in simple and complicated medication overuse headache: Advice alone as a withdrawal strategy for MOH, European Journal of Neurology, vol.18, issue.3, pp.396-401, 2011.

P. Rossi, J. V. Faroni, C. Tassorelli, and G. Nappi, Advice alone versus structured detoxification programmes for complicated medication overuse headache (MOH): a prospective, randomized, open-label trial. The journal of headache and pain, vol.14, p.10, 2013.
DOI : 10.1186/1129-2377-14-10

URL : https://thejournalofheadacheandpain.biomedcentral.com/track/pdf/10.1186/1129-2377-14-10

E. S. Kristoffersen, J. Straand, K. G. Vetvik, J. ?. Benth, M. B. Russell et al., Brief intervention for medication-overuse headache in primary care. The BIMOH study: a doubleblind pragmatic cluster randomised parallel controlled trial, Neurosurgery & Psychiatry, vol.86, issue.5, pp.505-517, 2015.

E. S. Kristoffersen, J. Straand, K. G. Vetvik, J. ?. Benth, M. B. Russell et al., Brief intervention by general practitioners for medication-overuse headache, follow-up after 6 months: a pragmatic cluster-randomised controlled trial, Journal of Neurology, vol.263, issue.2, pp.344-53, 2016.
DOI : 10.1007/s00415-015-7975-1

K. Hagen, C. Albretsen, S. Vilming, R. Salvesen, M. Grøning et al., Management of Medication Overuse Headache: 1-Year Randomized Multicentre Open-Label Trial, Cephalalgia, vol.29, issue.2, pp.221-253, 2009.
DOI : 10.1111/j.1468-2982.2008.01711.x

C. Chiang, T. J. Schwedt, S. Wang, and D. W. Dodick, Treatment of medication-overuse headache: A systematic review, Cephalalgia, vol.36, issue.4, pp.371-86, 2016.
DOI : 10.1177/0333102415593088

S. B. Munksgaard, L. Bendtsen, and R. H. Jensen, Detoxification of medication-overuse headache by a multidisciplinary treatment programme is highly effective: A comparison of two consecutive treatment methods in an open-label design, Cephalalgia, vol.32, issue.11, pp.834-878, 2012.

H. Diener, G. Bussone, J. V. Oene, M. Lahaye, S. Schwalen et al., Topiramate Reduces Headache Days in Chronic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study, Cephalalgia, vol.27, issue.7, pp.814-837, 2007.

C. Tassorelli, R. Jensen, A. M. , D. Icco, R. Sances et al., A consensus protocol for the management of medication-overuse headache: Evaluation in a multicentric, multinational study, Cephalalgia, vol.34, issue.9, pp.645-55, 2014.

L. Grazzi, F. Andrasik, D. D&apos;amico, M. Leone, S. Usai et al., Behavioral and Pharmacologic Treatment of Transformed Migraine With Analgesic Overuse: Outcome at 3 Years. Headache: The Journal of Head and Face Pain, vol.42, pp.483-490, 2002.

M. Rausa, D. Palomba, S. Cevoli, L. Lazzerini, E. Sancisi et al., Biofeedback in the prophylactic treatment of medication overuse headache: a pilot randomized controlled trial. The Journal of Headache and Pain, vol.17, 2016.

M. Altieri, D. Giambattista, R. , D. Clemente, L. Fagiolo et al., Combined Pharmacological and Short-Term Psychodynamic Psychotherapy for Probable Medication Overuse Headache: A Pilot Study, Cephalalgia, vol.29, issue.3, pp.293-302, 2009.

Z. Katsarava, G. Fritsche, M. Muessig, H. C. Diener, and V. Limmroth, Clinical features of withdrawal headache following overuse of triptans and other headache drugs, Neurology, vol.57, issue.9, pp.1694-1702, 2001.

K. Rabe, L. Pageler, C. Gaul, C. Lampl, T. Kraya et al., Prednisone for the treatment of withdrawal headache in patients with medication overuse headache: A randomized, double-blind, placebo-controlled study, Cephalalgia, vol.33, issue.3, pp.202-209, 2013.

S. Cevoli, G. Giannini, V. Favoni, R. Terlizzi, E. Sancisi et al., Treatment of withdrawal headache in patients with medication overuse headache: a pilot study. The Journal of Headache and Pain, vol.18, 2017.

F. Taghdiri, M. Togha, R. Jahromi, S. Paknejad, and S. , Celecoxib vs Prednisone for the Treatment of Withdrawal Headache in Patients With Medication Overuse Headache: A Randomized, Double-Blind Clinical Trial. Headache: The Journal of Head and Face Pain, vol.55, pp.128-163, 2015.

C. Lundqvist, R. B. Grande, K. Aaseth, and M. B. Russell, Dependence scores predict prognosis of medication overuse headache: A prospective cohort from the Akershus study of chronic headache: Pain, vol.153, pp.682-688, 2012.

I. Corbelli, S. Caproni, P. Eusebi, and P. Sarchielli, Drug-dependence behaviour and outcome of medication-overuse headache after treatment. The Journal of Headache and Pain, vol.13, pp.653-60, 2012.

G. Sances, N. Ghiotto, F. Galli, E. Guaschino, C. Rezzani et al., Risk factors in medication-overuse headache: A 1-year follow-up study (care II protocol), Cephalalgia, vol.30, issue.3, pp.329-365, 2010.

M. G. Bøe, R. Salvesen, and M. , Chronic daily headache with medication overuse: predictors of outcome 1 year after withdrawal therapy, European Journal of Neurology, vol.16, issue.6, pp.705-717, 2009.

J. Zidverc-trajkovic, T. Pekmezovic, Z. Jovanovic, A. Pavlovic, M. Mijajlovic et al., Medication Overuse Headache: Clinical Features Predicting Treatment Outcome at 1Year Follow-Up, Cephalalgia, vol.27, issue.11, pp.1219-1244, 2007.

A. Raggi, L. Grazzi, R. Ayadi, M. Leonardi, A. Proietti et al., Clinical and psychosocial features of frequent relapsers (FR) among patients with chronic migraine and medication overuse, Neurological Sciences, vol.38, issue.S1, pp.169-71, 2017.

K. Hagen, C. Albretsen, S. T. Vilming, R. Salvesen, M. Grønning et al., A 4-year follow-up of patients with medication-overuse headache previously included in a randomized multicentre study. The Journal of Headache and Pain, vol.12, pp.315-337, 2011.

Z. Katsarava, M. Muessig, A. Dzagnidze, G. Fritsche, H. Diener et al., Medication Overuse Headache: Rates and Predictors for Relapse in a 4-year Prospective Study, Cephalalgia, vol.25, issue.1, pp.12-17, 2005.

M. Bøe, R. Salvesen, and M. , Chronic Daily Headache with Medication Overuse: A Randomized Follow-Up by Neurologist or PCP, Cephalalgia, vol.29, issue.8, pp.855-63, 2009.

J. T. Lai, J. D. Dereix, R. P. Ganepola, P. G. Nightingale, K. A. Markey et al., Should we educate about the risks of medication overuse headache? The journal of headache and pain, vol.15, p.10, 2014.

. The-comoestas-consortium, S. B. Munksgaard, A. M. Tassorelli, C. Rossi, P. Katsarava et al., What do the patients with medication overuse headache expect from treatment and what are the preferred sources of information? The Journal of Headache and Pain, vol.12, pp.91-97, 2011.

E. De-diego, Modèle organisationnel d'un programme d'éducation thérapeutique destiné aux patients migraineux en situation ou avec risque de chronicisation ou d'abus d'usage de traitements, Douleur analg, vol.24, pp.214-221, 2011.

G. Fritsche, J. Frettlöh, M. Hüppe, M. Dlugaj, N. Matatko et al., Prevention of medication overuse in patients with migraine: Pain, vol.151, pp.404-417, 2010.

M. Linde, P. Jonsson, and T. Hedenrud, Influence of disease features on adherence to prophylactic migraine medication, Acta Neurologica Scandinavica, vol.118, issue.6, pp.367-72, 2008.

K. Luedtke, A. Allers, L. H. Schulte, and A. May, Efficacy of interventions used by physiotherapists for patients with headache and migraine-systematic review and meta-analysis, Cephalalgia, vol.36, issue.5, pp.474-92, 2016.

G. Giannini, SPARTACUS: underdiagnosis of chronic daily headache in primary care, Neurol Sci, issue.1, pp.181-183, 2012.

V. Rousselon and . Creac&apos;h-c, Céphalées par abus médicamenteux :Enquête auprès de 54 médecins généralistes, Rev Prat Med Gen, vol.19, pp.1230-1234, 2005.

M. Lanteri-minet, The role of general practitioners in migraine management, Cephalalgia, vol.28, pp.1-8, 2008.

W. Gorgels, O. Voshaar, R. C. Mol, A. Van-de-lisdonk, E. H. Van-balkom et al., Discontinuation of long-term benzodiazepine use by sending a letter to users in family practice: a prospective controlled intervention study. Drug and Alcohol Dependence, vol.78, pp.49-56, 2005.

J. O. Prochaska, C. C. Diclemente, and J. C. Norcross, In search of how people change: Applications to addictive behaviors, American psychologist, vol.47, issue.9, p.1102, 1992.